BRNS vs ECL
Barinthus Biotherapeutics plc (BRNS) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BRNS revenue for 2024-12-31 was $15.0M. Net income was -$61.2M. Revenue was up 1766.5% from 2023-12-31 to 2024-12-31. BRNS currently screens at market cap $38.2M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BRNS currently screens at market cap $38.2M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BRNS and ECL stock pages for the full models.
Not investment advice.